GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
March 4, 2025
Nurosene Completes Population Stratification Project For Major Pharmaceutical Company
May 18, 2022
Related Post
-
-
FOXO TECHNOLOGIES, INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR TWO ASSISTED-LIVING FACILITIES IN FLORIDA FOR A TOTAL CONSIDERATION OF $60 MILLION
February 24, 2025
-
Hydreight Technologies Partners with The DRIPBaR to Launch ‘DRIPBaR Direct’ Nationwide, Expanding Access to Direct-to-Consumer Healthcare Services
January 29, 2025
-
ATI Physical Therapy Announces the Termination of its Tender Offer to Purchase Up to 1,650,000 Shares of its Class A Common Stock at a Purchase Price of $2.85 per Share
January 16, 2025